Literature DB >> 16522671

Detection of a tandem BRCT in Nbs1 and Xrs2 with functional implications in the DNA damage response.

Emmanuelle Becker1, Vincent Meyer, Hocine Madaoui, Raphaël Guerois.   

Abstract

MOTIVATION: Human Nbs1 and its homolog Xrs2 in Saccharomyces cerevisiae are part of the conserved MRN complex (MRX in yeast) which plays a crucial role in maintaining genomic stability. NBS1 corresponds to the gene mutated in the Nijmegen breakage syndrome (NBS) known as a radiation hyper-sensitive disease. Despite the conservation and the importance of the MRN complex, the high sequence divergence between Nbs1 and Xrs2 precluded the identification of common domains downstream of the N-terminal Fork-Head Associated (FHA) domain.
RESULTS: Using HMM-HMM profile comparisons and structure modelling, we assessed the existence of a tandem BRCT in both Nbs1 and Xrs2 after the FHA. The structure-based conservation analysis of the tandem BRCT in Nbs1 supports its function as a phosphoserine binding domain. Remarkably, the 5 bp deletion observed in 95% of NBS patients cleaves the tandem at the linker region while preserving the structural integrity of each BRCT domain in the resulting truncated gene products.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16522671     DOI: 10.1093/bioinformatics/btl075

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  31 in total

1.  MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks.

Authors:  Liming Wu; Kuntian Luo; Zhenkun Lou; Junjie Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-04       Impact factor: 11.205

2.  MRE11-RAD50-NBS1 is a critical regulator of FANCD2 stability and function during DNA double-strand break repair.

Authors:  Céline Roques; Yan Coulombe; Mathieu Delannoy; Julien Vignard; Simona Grossi; Isabelle Brodeur; Amélie Rodrigue; Jean Gautier; Alicja Z Stasiak; Andrzej Stasiak; Angelos Constantinou; Jean-Yves Masson
Journal:  EMBO J       Date:  2009-07-16       Impact factor: 11.598

Review 3.  MRN and the race to the break.

Authors:  Agnieszka Rupnik; Noel F Lowndes; Muriel Grenon
Journal:  Chromosoma       Date:  2009-10-28       Impact factor: 4.316

4.  Spo11 and the Formation of DNA Double-Strand Breaks in Meiosis.

Authors:  Scott Keeney
Journal:  Genome Dyn Stab       Date:  2008-01-01

5.  Tel1 Activation by the MRX Complex Is Sufficient for Telomere Length Regulation but Not for the DNA Damage Response in Saccharomyces cerevisiae.

Authors:  Rebecca Keener; Carla J Connelly; Carol W Greider
Journal:  Genetics       Date:  2019-10-23       Impact factor: 4.562

6.  A point mutation in the Aspergillus nidulans sonBNup98 nuclear pore complex gene causes conditional DNA damage sensitivity.

Authors:  Colin P C De Souza; Shahr B Hashmi; Kevin P Horn; Stephen A Osmani
Journal:  Genetics       Date:  2006-10-08       Impact factor: 4.562

7.  The frequency of NBN molecular variants in pediatric astrocytic tumors.

Authors:  Dorota Piekutowska-Abramczuk; Elzbieta Ciara; Ewa Popowska; Wiesława Grajkowska; Bozenna Dembowska-Bagińska; Ewa Kowalewska; Aneta Czajńska; Marta Perek-Polnik; Marcin Roszkowski; Małgorzata Syczewska; Małgorzata Krajewska-Walasek; Danuta Perek; Krystyna H Chrzanowska
Journal:  J Neurooncol       Date:  2009-07-22       Impact factor: 4.130

8.  Structure of a second BRCT domain identified in the nijmegen breakage syndrome protein Nbs1 and its function in an MDC1-dependent localization of Nbs1 to DNA damage sites.

Authors:  Chao Xu; Liming Wu; Gaofeng Cui; Maria Victoria Botuyan; Junjie Chen; Georges Mer
Journal:  J Mol Biol       Date:  2008-06-14       Impact factor: 5.469

9.  DNA damage responses in Drosophila nbs mutants with reduced or altered NBS function.

Authors:  Sushmita Mukherjee; Matthew C LaFave; Jeff Sekelsky
Journal:  DNA Repair (Amst)       Date:  2009-04-22

10.  NBS1 Heterozygosity and Cancer Risk.

Authors:  Alessandra di Masi; Antonio Antoccia
Journal:  Curr Genomics       Date:  2008-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.